Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease.
International journal of cardiology
View this publicationInternational journal of cardiology
View this publicationFrontiers in medicine
View this publicationJAMA psychiatry
View this publicationAlzheimer's & dementia (Amsterdam, Netherlands)
View this publicationThe Lancet. Infectious diseases
View this publicationImmunity
View this publicationIndian journal of dermatology
View this publicationNature cell biology
View this publicationFrontiers in immunology
View this publicationHistopathology
View this publication